Subscribe to the gold package and get unlimited access to Shamra Academy
Register a new userInverse Projection Representation and Category Contribution Rate for Robust Tumor Recognition
78
0
0.0
(
0
)
Ask ChatGPT about the research
No Arabic abstract
Sparse representation based classification (SRC) methods have achieved remarkable results. SRC, however, still suffer from requiring enough training samples, insufficient use of test samples and instability of representation. In this paper, a stable inverse projection representation based classification (IPRC) is presented to tackle these problems by effectively using test samples. An IPR is firstly proposed and its feasibility and stability are analyzed. A classification criterion named category contribution rate is constructed to match the IPR and complete classification. Moreover, a statistical measure is introduced to quantify the stability of representation-based classification methods. Based on the IPRC technique, a robust tumor recognition framework is presented by interpreting microarray gene expression data, where a two-stage hybrid gene selection method is introduced to select informative genes. Finally, the functional analysis of candidates pathogenicity-related genes is given. Extensive experiments on six public tumor microarray gene expression datasets demonstrate the proposed technique is competitive with state-of-the-art methods.
rate research
Read More
Sparse representation classification achieves good results by addressing recognition problem with sufficient training samples per subject. However, SRC performs not very well for small sample data. In this paper, an inverse-projection group sparse representation model is presented for breast tumor classification, which is based on constructing low-rank variation dictionary. The proposed low-rank variation dictionary tackles tumor recognition problem from the viewpoint of detecting and using variations in gene expression profiles of normal and patients, rather than directly using these samples. The inverse projection group sparsity representation model is constructed based on taking full using of exist samples and group effect of microarray gene data. Extensive experiments on public breast tumor microarray gene expression datasets demonstrate the proposed technique is competitive with state-of-the-art methods. The results of Breast-1, Breast-2 and Breast-3 databases are 80.81%, 89.10% and 100% respectively, which are better than the latest literature.
Physicians use biopsies to distinguish between different but histologically similar enteropathies. The range of syndromes and pathologies that could cause different gastrointestinal conditions makes this a difficult problem. Recently, deep learning has been used successfully in helping diagnose cancerous tissues in histopathological images. These successes motivated the research presented in this paper, which describes a deep learning approach that distinguishes between Celiac Disease (CD) and Environmental Enteropathy (EE) and normal tissue from digitized duodenal biopsies. Experimental results show accuracies of over 90% for this approach. We also look into interpreting the neural network model using Gradient-weighted Class Activation Mappings and filter activations on input images to understand the visual explanations for the decisions made by the model.
We release the largest public ECG dataset of continuous raw signals for representation learning containing 11 thousand patients and 2 billion labelled beats. Our goal is to enable semi-supervised ECG models to be made as well as to discover unknown subtypes of arrhythmia and anomalous ECG signal events. To this end, we propose an unsupervised representation learning task, evaluated in a semi-supervised fashion. We provide a set of baselines for different feature extractors that can be built upon. Additionally, we perform qualitative evaluations on results from PCA embeddings, where we identify some clustering of known subtypes indicating the potential for representation learning in arrhythmia sub-type discovery.
Microarray gene expression data-based tumor classification is an active and challenging issue. In this paper, an integrated tumor classification framework is presented, which aims to exploit information in existing available samples, and focuses on the small sample problem and unbalanced classification problem. Firstly, an inverse space sparse representation based classification (ISSRC) model is proposed by considering the characteristics of gene-based tumor data, such as sparsity and a small number of training samples. A decision information factors (DIF)-based gene selection method is constructed to enhance the representation ability of the ISSRC. It is worth noting that the DIF is established from reducing clinical misdiagnosis rate and dimension of small sample data. For further improving the representation ability and classification stability of the ISSRC, feature learning is conducted on the selected gene subset. The feature learning method is constructed by complementing the advantages of non-negative matrix factorization (NMF) and deep learning. Without confusion, the ISSRC combined with gene selection and feature learning is called the integrated ISSRC, whose stability, optimization and the corresponding convergence are analyzed. Extensive experiments on six public microarray gene expression datasets show the integrated ISSRC-based tumor classification framework is superior to classical and state-of-the-art methods. There are significant improvements in classification accuracy, specificity and sensitivity, whether there is a tumor in the early diagnosis, what kind of tumor, or whether metastasis occurs after tumor surgery.
Computational systems and methods are being applied to solve biological problems for many years. Incorporating methods of this kind in the research for cancer treatment and related drug discovery in particular, is shown to be challenging due to the complexity and the dynamic nature of the related factors. Usually, there are two objectives in such settings; first to calibrate the simulators so as to reproduce real-world cases, and second, to search for specific values of the parameter space concerning effective drug treatments. We combine a multi-scale simulator for tumor cell growth and a Genetic Algorithm (GA) as a heuristic search method for finding good parameter configurations in reasonable time. The two modules are integrated into a single workflow that can be executed in a parallel manner on high performance computing infrastructures, since large-scale computational and storage capabilities are necessary in this domain. After using the GA for calibration, our goal is to explore different drug delivery schemes. Among these schemes, we aim to find those that minimize tumor cell size and the probability of emergence of drug resistant cells in the future. Results from experiments on high performance computing infrastructure illustrate the effectiveness and timeliness of the approach.
suggested questions
Log in to be able to interact and post comments
comments
Fetching comments
Sign in to be able to follow your search criteria
